Education
About Us
Working with TipRanks
Follow Us
Spago Nanomedical AB (SE:SPAGO)
:SPAGO
SPAGO Stock Chart & Stats
kr0.10
kr0.00(0.00%)
At close: 4:00 PM EST
kr0.10
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.06 - kr0.33
Previous CloseN/A
Volume33.85K
Average Volume (3M)1.01M
Market Cap
kr86.67M
Enterprise Valuekr34.83M
Total Cash (Recent Filing)kr18.52M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding661,572,800
10 Day Avg. Volume1,158,815
30 Day Avg. Volume1,005,829
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.74
Price to Sales (P/S)30.30
P/FCF Ratio-1.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPAGO FAQ
What was Spago Nanomedical AB’s price range in the past 12 months?
Spago Nanomedical AB lowest stock price was kr0.06 and its highest was kr0.33 in the past 12 months.
What is Spago Nanomedical AB’s market cap?
Spago Nanomedical AB’s market cap is kr86.67M.
When is Spago Nanomedical AB’s upcoming earnings report date?
Spago Nanomedical AB’s upcoming earnings report date is Apr 29, 2026 which is in 86 days.
How were Spago Nanomedical AB’s earnings last quarter?
Currently, no data Available
Is Spago Nanomedical AB overvalued?
According to Wall Street analysts Spago Nanomedical AB’s price is currently Overvalued.
Does Spago Nanomedical AB pay dividends?
Spago Nanomedical AB does not currently pay dividends.
What is Spago Nanomedical AB’s EPS estimate?
Spago Nanomedical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spago Nanomedical AB have?
Spago Nanomedical AB has 661,572,800 shares outstanding.
What happened to Spago Nanomedical AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Spago Nanomedical AB?
Currently, no hedge funds are holding shares in SE:SPAGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Spago Nanomedical AB
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
Technical Analysis
Biosergen AB
―
Nanologica AB
―
Lipigon Pharmaceuticals AB
―
Modus Therapeutics Holding AB
―
NextCell Pharma AB
―